Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.36%103.89B | -0.17%462.08B | 5.60%112.15B | 2.54%462.87B | 6.97%121.08B | 1.62%122.16B | 1.17%113.43B | 0.29%106.2B | 10.59%451.41B | 6.92%113.19B |
| Cost of revenue | -2.62%65.17B | -2.00%285.94B | 0.48%66.92B | 4.11%291.78B | 9.03%79.4B | 2.12%75.19B | 2.30%70.53B | 2.65%66.6B | 10.58%280.27B | 7.62%72.82B |
| Gross profit | -14.39%38.72B | 2.96%176.14B | 14.22%45.23B | -0.03%171.08B | 3.25%41.68B | 0.82%46.97B | -0.63%42.9B | -3.45%39.6B | 10.60%171.14B | 5.67%40.37B |
| Operating expense | -5.28%34.13B | 9.41%155.45B | 10.07%36.04B | 13.98%142.08B | 15.97%38.31B | 14.27%36.77B | 15.52%34.1B | 9.39%32.74B | 18.27%124.66B | 12.03%33.03B |
| Selling and administrative expenses | -5.45%34.02B | 1.45%139.42B | 9.28%35.98B | 9.70%137.43B | 7.79%35.82B | 6.89%34.5B | 14.72%34.11B | 9.64%32.93B | 12.14%125.27B | 10.68%33.24B |
| -General and administrative expense | -5.45%34.02B | 1.45%139.42B | 9.28%35.98B | 9.70%137.43B | 7.79%35.82B | 6.89%34.5B | 14.72%34.11B | 9.64%32.93B | 12.14%125.27B | 10.68%33.24B |
| Other operating expenses | -33.82%274M | 198.74%18.3B | 365.17%414M | 340.89%6.12B | 486.06%2.9B | 530.23%2.5B | 73.08%540M | -51.63%89M | 11.12%1.39B | -8.16%495M |
| Total other operating income | -54.27%166M | 54.35%2.27B | 30.11%363M | -26.72%1.47B | -40.32%416M | -53.56%228M | 4.37%549M | -3.79%279M | -73.46%2.01B | -35.52%697M |
| Operating profit | -50.08%4.59B | -28.64%20.7B | 34.01%9.19B | -37.62%29B | -54.05%3.37B | -29.21%10.2B | -35.55%8.8B | -38.11%6.86B | -5.78%46.48B | -15.83%7.33B |
| Net non-operating interest income (expenses) | -118.98%-801M | -79.53%1.77B | 32.70%4.22B | 112.17%8.63B | 250.18%4.8B | 7.86%-2.47B | -19.71%3.13B | 113.57%3.18B | 10.24%4.07B | -44.09%1.37B |
| Non-operating interest income | -82.89%747M | -49.62%4.63B | 32.66%4.37B | 103.86%9.19B | 237.45%4.95B | 18.53%614M | -18.79%3.25B | 104.92%3.29B | -22.15%4.51B | -42.46%1.47B |
| Non-operating interest expense | 960.27%1.55B | 410.52%2.86B | 31.53%146M | 27.21%561M | 53.68%146M | -3.59%3.09B | 13.51%126M | -5.13%111M | -79.02%441M | -1.04%95M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -71.75%3.79B | -40.31%22.46B | 33.59%13.41B | -25.56%37.63B | -6.15%8.17B | -34.10%7.73B | -32.04%11.93B | -20.15%10.04B | -4.67%50.55B | -22.04%8.7B |
| Income tax | -64.98%1.39B | 14.54%8.99B | 20.56%3.96B | -36.55%7.85B | -256.28%-858M | -22.93%1.96B | -35.09%3.46B | -16.78%3.29B | -21.01%12.38B | -85.67%549M |
| Net income | -74.61%2.4B | -54.77%13.47B | 39.93%9.45B | -22.01%29.78B | 10.68%9.03B | -37.21%5.76B | -30.70%8.47B | -21.70%6.75B | 2.18%38.18B | 11.22%8.16B |
| Net income continuous operations | -74.61%2.4B | -54.77%13.47B | 39.93%9.45B | -22.01%29.78B | 10.68%9.03B | -37.21%5.76B | -30.70%8.47B | -21.70%6.75B | 2.18%38.18B | 11.22%8.16B |
| Noncontrolling interests | -42.86%16M | -13.43%116M | -3.45%28M | 2,333.33%134M | 547.83%103M | 52.17%-11M | 18.18%13M | 0.00%29M | -106.52%-6M | -135.38%-23M |
| Net income attributable to the company | -74.71%2.38B | -54.96%13.35B | 40.13%9.42B | -22.37%29.64B | 9.10%8.92B | -37.24%5.77B | -30.76%8.46B | -21.78%6.72B | 2.46%38.18B | 12.57%8.18B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -74.71%2.38B | -54.96%13.35B | 40.13%9.42B | -22.37%29.64B | 9.10%8.92B | -37.24%5.77B | -30.76%8.46B | -21.78%6.72B | 2.46%38.18B | 12.57%8.18B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -72.39%5.26 | -52.90%27.58 | 44.17%19.05 | -21.09%58.56 | 11.19%17.72 | -36.18%11.4033 | -29.58%16.7 | -20.85%13.2133 | 3.62%74.2133 | 12.60%15.9367 |
| Diluted earnings per share | -72.39%5.26 | -52.90%27.58 | 44.17%19.05 | -21.09%58.56 | 11.19%17.72 | -36.18%11.4033 | -29.58%16.7 | -20.85%13.2133 | 3.62%74.2133 | 12.87%15.9367 |
| Dividend per share | 0 | 2.70%25.3333 | 0 | 12.12%24.6667 | 12.12%12.3333 | 0 | 12.12%12.3333 | 0 | 0.00%22 | 0.00%11 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |